Xiaochen Yu

1.5k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Xiaochen Yu is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Xiaochen Yu has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Physiology. Recurrent topics in Xiaochen Yu's work include Pancreatic function and diabetes (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Autophagy in Disease and Therapy (4 papers). Xiaochen Yu is often cited by papers focused on Pancreatic function and diabetes (5 papers), Metabolism, Diabetes, and Cancer (4 papers) and Autophagy in Disease and Therapy (4 papers). Xiaochen Yu collaborates with scholars based in China, Japan and United Kingdom. Xiaochen Yu's co-authors include Mei Xue, Liming Chen, Bei Sun, Linxin Xu, Ying Cheng, Yunhong Lu, Xiangyang Liu, Xiaoyu Li, Jie Zhang and Ting Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Diabetologia and Molecules.

In The Last Decade

Xiaochen Yu

31 papers receiving 1.1k citations

Hit Papers

SGLT2 inhibition with empagliflozin attenuates myocardial... 2019 2026 2021 2023 2019 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
    2019 442 citations Chenguang Li, Jie Zhang et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaochen Yu China 14 483 418 292 267 139 32 1.1k
Yunhong Lu China 8 393 0.8× 395 0.9× 252 0.9× 254 1.0× 72 0.5× 12 917
Linxin Xu China 11 362 0.7× 433 1.0× 272 0.9× 265 1.0× 116 0.8× 23 894
Mitchel Tate Australia 17 512 1.1× 319 0.8× 212 0.7× 350 1.3× 119 0.9× 29 1.1k
Ornella Carbonara Italy 15 324 0.7× 383 0.9× 189 0.6× 385 1.4× 92 0.7× 22 998
Shawna A. Cooper United States 16 432 0.9× 346 0.8× 235 0.8× 385 1.4× 263 1.9× 22 1.3k
Subhash K. Das Canada 19 412 0.9× 189 0.5× 311 1.1× 591 2.2× 167 1.2× 27 1.4k
Xuemian Lu China 20 688 1.4× 272 0.7× 142 0.5× 136 0.5× 123 0.9× 37 1.4k
Shengyu Mu United States 15 354 0.7× 287 0.7× 177 0.6× 184 0.7× 123 0.9× 39 1.1k
Chuanming Xu China 16 479 1.0× 569 1.4× 225 0.8× 582 2.2× 164 1.2× 47 1.2k
Takeyoshi Murano Japan 24 292 0.6× 418 1.0× 334 1.1× 347 1.3× 265 1.9× 52 1.2k

Countries citing papers authored by Xiaochen Yu

Since Specialization
Citations

This map shows the geographic impact of Xiaochen Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Yu more than expected).

Fields of papers citing papers by Xiaochen Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochen Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Yu. The network helps show where Xiaochen Yu may publish in the future.

Co-authorship network of co-authors of Xiaochen Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochen Yu. A scholar is included among the top collaborators of Xiaochen Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochen Yu. Xiaochen Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chao, et al.. (2025). Macrophages Unmasked: Their Pivotal Role in Driving Atherosclerosis in Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology. 68(1). 10–10. 4 indexed citations
2.
Yu, Xiaochen, Ke Sheng, Tong Fu, et al.. (2025). Apolipoprotein B100 acts as a tumor suppressor in ovarian cancer via lipid/ER stress axis-induced blockade of autophagy. Acta Pharmacologica Sinica. 46(5). 1445–1461. 2 indexed citations
3.
Yu, Xiaochen, et al.. (2024). Glycoprotein non-metastatic melanoma protein B (GPNMB): An attractive target in atherosclerosis. Biochemical and Biophysical Research Communications. 732. 150386–150386. 4 indexed citations
4.
Li, Xiaoyu, Xiangyang Liu, Linxin Xu, et al.. (2023). Integrin β6 mediates epithelial–mesenchymal transition in diabetic kidney disease. Molecular and Cellular Endocrinology. 572. 111955–111955. 3 indexed citations
5.
Liu, Rui, Na Zhu, Xinran Liu, et al.. (2023). The Protective Effect of Walnut Oligopeptides against Indomethacin-Induced Gastric Ulcer in Rats. Nutrients. 15(7). 1675–1675. 8 indexed citations
6.
He, Peng, Hongchuan Liu, Rui Wang, et al.. (2023). Enhanced chemoimmunotherapy of breast cancer in mice by apolipoprotein A1-modified doxorubicin liposomes combined with interleukin-21. Journal of drug targeting. 31(10). 1098–1110. 4 indexed citations
7.
You, Mei, Rui Liu, Xiujuan Wang, et al.. (2023). Exogenous Nucleotides Ameliorate Ageing-Related Intestinal Inflammation in Senescence-Accelerated Mouse Prone-8 (SAMP8) Mice. Nutrients. 15(11). 2533–2533. 4 indexed citations
8.
Yu, Xiaochen, et al.. (2023). Trimethylamine N-oxide promotes oxidative stress and lipid accumulation in macrophage foam cells via the Nrf2/ABCA1 pathway. Journal of Physiology and Biochemistry. 80(1). 67–79. 19 indexed citations
9.
10.
Wang, Shuqing, Meiqi Wang, Yue Cheng, et al.. (2022). Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital in Northern China. Canadian Journal of Infectious Diseases and Medical Microbiology. 2022. 1–11. 3 indexed citations
11.
Yu, Xiaochen, Ziyu Meng, Ting Fang, et al.. (2022). Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway. Frontiers in Physiology. 13. 817542–817542. 12 indexed citations
12.
Wu, Xin, Xiaochen Yu, Na Zhu, Meihong Xu, & Yong Li. (2022). Beneficial effects of whey protein peptides on muscle loss in aging mice models. Frontiers in Nutrition. 9. 897821–897821. 11 indexed citations
13.
Li, Ting, Ting Fang, Linxin Xu, et al.. (2021). Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro. Frontiers in Pharmacology. 11. 622153–622153. 21 indexed citations
14.
Yu, Xiaochen, Rui Wang, Peng He, et al.. (2021). Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules. 26(5). 1280–1280. 16 indexed citations
15.
Xu, Linxin, Chaofei Xu, Xiaoyu Li, et al.. (2021). Empagliflozin Induces White Adipocyte Browning and Modulates Mitochondrial Dynamics in KK Cg-Ay/J Mice and Mouse Adipocytes. Frontiers in Physiology. 12. 745058–745058. 24 indexed citations
16.
Li, Xiaoyu, Rong Xu, Xiangyang Liu, et al.. (2020). Urinary miR‐3137 and miR‐4270 as potential biomarkers for diabetic kidney disease. Journal of Clinical Laboratory Analysis. 34(12). e23549–e23549. 4 indexed citations
17.
Xue, Mei, Ting Li, Yue Wang, et al.. (2019). Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice. Clinical Science. 133(15). 1705–1720. 85 indexed citations
18.
Cheng, Ying, Xiaochen Yu, Jie Zhang, et al.. (2019). Pancreatic kallikrein protects against diabetic retinopathy in KK Cg-Ay/J and high-fat diet/streptozotocin-induced mouse models of type 2 diabetes. Diabetologia. 62(6). 1074–1086. 63 indexed citations
19.
Li, Chenguang, Jie Zhang, Mei Xue, et al.. (2019). SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart. Cardiovascular Diabetology. 18(1). 15–15. 442 indexed citations breakdown →
20.
Wang, Yue, Yunhong Lu, Chao Tang, et al.. (2019). Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway. Frontiers in Pharmacology. 10. 886–886. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunhong Lu Breakdown of academic impact, for papers by Linxin Xu Breakdown of academic impact, for papers by Mitchel Tate Breakdown of academic impact, for papers by Ornella Carbonara Breakdown of academic impact, for papers by Shawna A. Cooper Breakdown of academic impact, for papers by Subhash K. Das Breakdown of academic impact, for papers by Xuemian Lu Breakdown of academic impact, for papers by Shengyu Mu Breakdown of academic impact, for papers by Chuanming Xu Breakdown of academic impact, for papers by Takeyoshi Murano
Rankless by CCL
2026